BSE filing, NSE: KERNEX. Summary written from the filing by ALFA Finder's alert engine.
Kernex Microsystems (India) Ltd: key numbers
- Share price
- ₹1,612.40
- Market cap
- ₹2,709 Cr
- Revenue (annual)
- ₹430.2 Cr
- Net profit (annual)
- ₹88.34 Cr
- P/E (TTM)
- 14.2×Sector 28.1×
- Promoter holding
- 28.73%+0.00% QoQ
- FII holding
- 1.19%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kernex Microsystems (India) Ltd
All →Kernex Microsystems (India) Other Announcement
Kernex Microsystems India Ltd has filed its quarterly shareholding pattern statement for the period ended September 30, 2026, as required under SEBI regulations.
Kernex Microsystems (India) Annual Report
Kernex Microsystems submitted its revised 34th Annual Report for the financial year 2025-26, following adoption by shareholders at the AGM on 30th September 2026.
Kernex Microsystems (India) Annual General Meeting
Kernex Microsystems (India) Ltd held its 34th Annual General Meeting on September 30, 2026. Shareholders considered resolutions for financial statement adoption, director re-appointments, and auditor remuneration ratification.
Kernex Microsystems (India) Annual Report
Kernex Microsystems filed an addendum to its FY25-26 Board's Report, part of the 34th Annual Report. It updates re-appointment and changes of Independent Directors.
Kernex Microsystems (India) Annual Report
Kernex Microsystems has filed its 34th Annual Report for FY 2025-26 with the exchange, including the notice for the upcoming Annual General Meeting.
Kernex Microsystems (India) Annual General Meeting
Kernex Microsystems (India) Ltd. issued a notice for its 34th Annual General Meeting to be held on September 30, 2026, via video conference.
Other credit rating announcements
All →Epigral Credit Rating
CRISIL revised Epigral's ratings to CRISIL AA/Stable (long-term) and CRISIL A1+ (short-term) on its bank facilities. The action covers Rs.1,050 Crore of rated bank loan facilities.
Mankind Pharma Credit Rating
CRISIL reaffirmed Mankind Pharma's AA+ rating on Rs.2,500 Crore of NCDs and withdrew ratings on Rs.2,500 Crore NCDs and Rs.1,500 Crore commercial paper. The rating action is dated October 29, 2026.
Lloyds Metals & Energy Credit Rating
Crisil Ratings reaffirmed Lloyds Metals' bank facilities at AA/Stable and A1+, with bank limits enhanced to ₹17,112 crore. It assigned AA/Stable to ₹2,400 crore and ₹1,550 crore of NCDs.
Ram Ratna Wires Credit Rating
CARE Ratings assigned and reaffirmed Ram Ratna Wires' bank facility ratings at CARE A-; Positive / CARE A2+ and revised outlook from Stable to Positive. The long-term bank facilities total Rs.1,046.45 Crore, with several facilities enhanced.
Adani Ports & Special Economic Zone Credit Rating
Fitch Ratings affirmed Adani Ports' Long-Term Foreign-Currency IDR and unsecured notes at 'BBB-' with a Stable outlook. The affirmation keeps the existing rating unchanged.
Capri Global Capital Credit Rating
India Ratings affirmed CGCL's credit rating at IND AA- with Positive outlook. A new Rs. 500 Cr bank loan facility was also assigned the same rating.